Wiebe Olijve
Plus aucun poste en cours
Profil
Wiebe Olijve was the founder of Organon USA, Inc. (founded in 2005) and Aduro Biotech Holdings Europe BV (founded in 2011), where he held the title of Chief Executive Officer.
He previously worked as Vice President-Research at N.V.
Organon from 1972 to 2007 and as a Professor-Applied Biology at Radboud University Nijmegen from 1990 to 2013.
He also worked as Vice President at Schering-Plough Biopharma from 2007 to 2009.
Olijve earned a doctorate degree from the University of Groningen in 1972.
Anciens postes connus de Wiebe Olijve
Sociétés | Poste | Fin |
---|---|---|
Radboud University Nijmegen | Corporate Officer/Principal | 01/01/2013 |
Schering-Plough Biopharma
Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | Corporate Officer/Principal | - |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Directeur Technique/Scientifique/R&D | 01/01/2007 |
Organon USA, Inc. | Fondateur | - |
Aduro Biotech Holdings Europe BV
Aduro Biotech Holdings Europe BV BiotechnologyHealth Technology Aduro Biotech Holdings Europe BV operates as a biopharmaceutical company specializing in immune oncology antibody discovery. The firm’s technology creates a pipeline of antibodies aiming to treat the immune system of cancer patients. Its antibody portfolio includes immune checkpoint inhibitors and novel antibody formats. The company was founded by Wiebe Olijve, Andrea van Elsas, and Hans van Eenennaam in 2011 and is headquartered in Oss, the Netherlands. | Directeur Général | - |
Formation de Wiebe Olijve
University of Groningen | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
Aduro Biotech Holdings Europe BV
Aduro Biotech Holdings Europe BV BiotechnologyHealth Technology Aduro Biotech Holdings Europe BV operates as a biopharmaceutical company specializing in immune oncology antibody discovery. The firm’s technology creates a pipeline of antibodies aiming to treat the immune system of cancer patients. Its antibody portfolio includes immune checkpoint inhibitors and novel antibody formats. The company was founded by Wiebe Olijve, Andrea van Elsas, and Hans van Eenennaam in 2011 and is headquartered in Oss, the Netherlands. | Health Technology |
Organon USA, Inc. | |
Schering-Plough Biopharma
Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | Commercial Services |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Health Technology |